GeneCradle Therapeutics to Speak at ACCESS CHINA BD Forum @ BIO

June 15, 2025 (Boston) — We are glad to announce that Xiaodong Wang, Ph.D, the Vice president, International Business & Affairs of GeneCradle Therapeutics, will be presenting at the ACCESS CHINA BD Forum @BIO on June 15, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.

About GeneCradle Therapeutics Co., Ltd.

Beijing GeneCradle Therapeutics Co., Ltd. is a leading national high-tech enterprise specializing in the development of gene therapy drugs mediated by AAV vector delivery technology. The company focuses on the development of gene drugs for genetic neuromuscular diseases, inherited metabolic diseases, lysosomal diseases, and ophthalmic diseases. Through advancing research and clinical application of gene drugs for rare diseases, the company aims to deepen our understanding of life and health, while expanding the application of gene therapy to the treatment and recovery of chronic and other significant illnesses.

About ACCESS CHINA BD Forum @BIO

‘ACCESS CHINA BD Forum @BIO is scheduled to be held on June 15, 2025, at Seaport Boston Hotel. This year’s ACCESS CHINA BD Forum @BIO will convene 80 distinguished guests for an afternoon of strategic networking, business development, and thought leadership, with a special emphasis on China’s dynamic biotechnology landscape and global collaboration opportunities.

Conference Name: ACCESS CHINA BD Forum @BIO

Date: June 15, 2025

Content: Keynote Speeches, Panel Discussion, 10 Elevator Pitch, and Closed-Door Dinner Reception.

Participants: Pharma/Biotech senior management and BD’s

View more information at https://biotochina.org/